drugset / Trial / NCT02561585

LEO 124249 Ointment in the Treatment of Alopecia Areata

NCT02561585

Phase 2 Completed 40 enrolled LEO Pharma
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This clinical trial attempts to investigate the efficacy and safety of LEO 124249 ointment in the treatment of alopecia areata and the molecular disease mechanism and biomarkers.

Timeline

Start
2016-01
Primary completion
2016-12
Completion
2016-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Delgocitinib Small molecule 30 unknown Topical

Indications